- Home
- RNA vs KD Comparison
RNA vs KD Comparison
Compare RNA & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- KD
- Stock Information
- Founded
- RNA 2012
- KD 2020
- Country
- RNA United States
- KD United States
- Employees
- RNA N/A
- KD N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- KD EDP Services
- Sector
- RNA Health Care
- KD Technology
- Exchange
- RNA Nasdaq
- KD Nasdaq
- Market Cap
- RNA 5.5B
- KD 5.3B
- IPO Year
- RNA 2020
- KD N/A
- Fundamental
- Price
- RNA $45.28
- KD $27.72
- Analyst Decision
- RNA Strong Buy
- KD Buy
- Analyst Count
- RNA 9
- KD 4
- Target Price
- RNA $63.22
- KD $30.25
- AVG Volume (30 Days)
- RNA 1.0M
- KD 1.9M
- Earning Date
- RNA 11-07-2024
- KD 11-06-2024
- Dividend Yield
- RNA N/A
- KD N/A
- EPS Growth
- RNA N/A
- KD N/A
- EPS
- RNA N/A
- KD N/A
- Revenue
- RNA $10,117,000.00
- KD $15,299,000,000.00
- Revenue This Year
- RNA $19.85
- KD N/A
- Revenue Next Year
- RNA N/A
- KD $1.75
- P/E Ratio
- RNA N/A
- KD N/A
- Revenue Growth
- RNA N/A
- KD N/A
- 52 Week Low
- RNA $5.68
- KD $17.62
- 52 Week High
- RNA $56.00
- KD $28.93
- Technical
- Relative Strength Index (RSI)
- RNA 48.69
- KD 68.79
- Support Level
- RNA $45.65
- KD $27.91
- Resistance Level
- RNA $56.00
- KD $28.93
- Average True Range (ATR)
- RNA 3.07
- KD 0.84
- MACD
- RNA 0.30
- KD 0.42
- Stochastic Oscillator
- RNA 31.59
- KD 82.80
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.